Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Annette Bjerre

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Ugeskrift for Laeger|March 27, 2024
Christina Annette Bjerre, Jeanette Dupont Rønlev, Ann Søegaard Knop
Nature Medicine|December 9, 2022
Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trialAndreas Hagen Røssevold, Nikolai Kragøe Andresen, Christina Annette Bjerre, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Ugeskrift for Laeger|March 27, 2024
Christina Annette Bjerre, Jeanette Dupont Rønlev, Ann Søegaard Knop
Nature Medicine|December 9, 2022
Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trialAndreas Hagen Røssevold, Nikolai Kragøe Andresen, Christina Annette Bjerre, et al.
Pageof 1